Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mercurius Health is a European healthcare services company focused on advanced oncology solutions for hospitals and cancer centers rather than a drug-development biotech. The company provides advisory services, project delivery, outsourced operations, training, data enhancement, equipment financing, radiotherapy support, nuclear medicine services, and cyclotron-based radiopharmaceutical production. Its work spans radiotherapy, PET and other nuclear medicine capabilities, and remote treatment planning through its proprietary Mercurius Connect platform. Mercurius has also operated clinical assets, including radiotherapy and imaging centers, and expanded into Germany through the Robert Janker Klinik acquisition. Mercurius Health's Iberian activities became part of Alliance Medical effective October 2, 2025, while the broader company had previously been acquired by iCON Infrastructure in May 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mercurius Health.